Journal:
:hepatitis monthly
0
wen jia department of infectious diseases, huashan hospital, fudan university, shanghai, china; department of infectious diseases, jing’an district centre, shanghai hospital, fudan university, shanghai, china
xun qi department of infectious diseases, huashan hospital, fudan university, shanghai, china
yan-yan ji department of infectious diseases, jing’an district centre, shanghai hospital, fudan university, shanghai, china
yun-hao xun department of liver diseases, xixi hospital of hangzhou, zhejiang chinese medical university, hangzhou, china
hong wang department of infectious diseases, jing’an district centre, shanghai hospital, fudan university, shanghai, china
wen-hong zhang department of infectious diseases, huashan hospital, fudan university, shanghai, china; department of infectious diseases, jing’an district centre, shanghai hospital, fudan university, shanghai, china
conclusions in hbeag positive chb patients, low serum hbsag level is a useful predictor of compensated cirrhosis. objectives the aim of our study was to evaluate serum hbsag level as a biomarker for compensated cirrhosis in hepatitis b e antigen (hbeag) positive chb patients. patients and methods two-hundred and one hbeag-positive chinese chb patients with or without cirrhosis were enrolled in ...
